|
Volumn 7, Issue 6, 2004, Pages 575-581
|
Drug evaluation: Bay-59-8862.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BRIDGED COMPOUND;
ORTATAXEL;
TAXOID;
ANIMAL;
BREAST TUMOR;
DRUG SCREENING;
FEMALE;
HUMAN;
OVARY TUMOR;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REVIEW;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
BRIDGED COMPOUNDS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
DRUG EVALUATION, PRECLINICAL;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
STRUCTURE-ACTIVITY RELATIONSHIP;
TAXOIDS;
|
EID: 4444239784
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (5)
|
References (42)
|